ID1 and chronic myelogenous leukemia, BCR-ABL1 positive: Our research has revealed that the downregulated miR-29b in the demethylating drug decitabine (DAC)-resistant chronic myeloid leukemia cell line (K562/DAC) leads to abnormal upregulation of ID1 and resistance to apoptosis.